Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 17, 2014

View Archived Issues

Nihon Medi-Physics and Endocyte sign license agreement for companion diagnostic

Moderna launches new venture to focus on development of mRNA Therapeutics in oncology

Elixir Medical confirms first commercial implant of the DESolve scaffold system

Sanofi and Fraunhofer-Gesellschaft form natural product center of excellence for infectious diseases

Mass General, Broad Institute and Amgen form collaboration to treat IBD

IntegraGen enters collaboration to validate oncology biomarker

Resverlogix reports results from analysis of combined data from SUSTAIN and ASSURE trials

Patch under development by Taisho and Tokuhon shows efficacy in phase III trials in osteoarthritis

Tafinlar receives FDA breakthrough therapy designation for NSCLC with BRAF mutation

TS-734 shows promise as PET-imaging agent for early detection and treatment of Alzheimer's disease

Nab-paclitaxel shows promise in esophageal squamous cell carcinoma trial

Identification of a risk factor inversely correlated with cardiometabolic disease

Cytonet files MAA with EMA for use of liver cell therapy to treat urea cycle disorders in children

Japan Tobacco and Torii gain approval for Riona Tablets in Japan

Suglat tablets approved for treatment of type 2 diabetes in Japan

Xyzal syrup for allergic disease gains approval in Japan

SYK inhibitors revealed in Portola patents

Status updates provided for phase III METIV-HCC and ATTENTION trials of tivantinib

Metabotropic glutamate mGlu5 receptor PAMs reported in Vanderbilt University patent

Takeda obtains approval of Adcetris for treatment of malignant lymphoma in Japan

Merck & Co. researchers report discovery of SYK inhibitors

Torii's sublingual immunotherapy drug for Japanese cedar pollinosis approved in Japan

Japanese MHLW approves Bayer's Adempas for CTEPH

FDA committee votes against approval of rivaroxaban for ACS indication

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...